Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-09
2007-01-09
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S230500, C514S250000, C514S253060, C514S264100, C544S362000, C544S363000, C544S105000, C544S279000, C544S350000
Reexamination Certificate
active
10900210
ABSTRACT:
This invention relates to compounds of the formula 1wherein G, D, A, Z, Q, X, Y, R1, and R4through R7are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
REFERENCES:
patent: 5006528 (1991-04-01), Oshiro et al.
patent: 5206366 (1993-04-01), Bowles
patent: 5350747 (1994-09-01), Howard
patent: 5641779 (1997-06-01), Halazy et al.
patent: 5945422 (1999-08-01), Doherty et al.
patent: 6127357 (2000-10-01), Cliffe et al.
patent: 6414157 (2002-07-01), Lubisch et al.
patent: 0 367 141 (1990-05-01), None
patent: 0 372 776 (1990-06-01), None
patent: 0 431 945 (1991-06-01), None
patent: 0 402 644 (1995-08-01), None
patent: 0 814084 (1997-12-01), None
patent: 56049361 (1981-05-01), None
patent: 09241161 (1997-09-01), None
patent: WO 93/04684 (1993-03-01), None
patent: WO 94/13643 (1994-06-01), None
patent: WO 94/13644 (1994-06-01), None
patent: WO 94/13661 (1994-06-01), None
patent: WO 94/13676 (1994-06-01), None
patent: WO 94/13677 (1994-06-01), None
patent: WO 96/26936 (1996-09-01), None
patent: WO 96/34867 (1996-11-01), None
patent: WO 97/03067 (1997-01-01), None
patent: WO 97/14419 (1997-04-01), None
patent: WO 98/42712 (1998-10-01), None
patent: WO 99/56672 (1999-11-01), None
patent: WO 01/46177 (2001-06-01), None
patent: WO 02/16354 (2002-02-01), None
patent: WO 02/48105 (2002-06-01), None
patent: WO 02/56882 (2002-07-01), None
patent: WO 02/060423 (2002-08-01), None
patent: WO 03/002556 (2003-01-01), None
patent: WO 04/046124 (2004-06-01), None
patent: WO 2004/087145 (2004-10-01), None
Cecchetti et al, “Synthesis and B-adrenergic blocking activity of 1,4-benzothiazine oxime ethers,” Eur.J.Med.Chem., (1989), pp. 479-484, vol. 24.
Chaudhary et al., “4-Dimethylaminopyridine: An Efficient and Selective Catalyst for the Silylation of Alcohols,” Tetrahedron Letters, No. 2., (1979), pp. 99-102.
Freeman et al, “The Quinoxalinols. I. Correlation Between Antibacterial Activity and Chelating Ability,” J. Org. Chem., (1951), pp. 438-442, vol. 16.
Hernandez et al, “Solid-Supported tert-Alkoxycarbonylation Reagents for Anchoring of Amines during Solid Phase Organic Synthesis,” J. Org. Chem., (1997), pp. 3153-3157, vol. 62.
Kerrigan et al., “Synthesis of ARylpiperazines via Palladium-Catalysed Aromatic Amination Reactions of Bromoarenes with N-tert-Butoxycarbonylpiperazine,” Tetrahedron Letters, (1998), pp. 2219-2222, vol. 39.
Miyaura et al., “Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds,” Chem. Rev., (1995), pp. 2457-2483, vol. 95.
Newkome et al., “Chemistry of Heterocyclic Compounds. tl. Synthesis and Conformational STudies of Macrocycles Possessing 1,8- or 1,5-Naphthyridonio Subunits Connected by Carbon-Oxygen Bridges,” J. Org. Chem., (1981), pp. 833-839, vol. 46.
Pierce et al., “Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor,” J. Org. Chem., (1998), pp. 8536-8543, vol. 63.
Marburg et al., “A short Efficient Synthesis of 4-Amino-2,3-dihydrobenzofuran,” J. Heterocyclic Chem., (1980), pp. 1333-1335, vol. 17.
Shuto et al., “One-Pot Conversion of a,B-Unsaturated Alcohols into the Corresponding Carbon-Elongated Dienes with a Stable Phosphorus Ylide-BaMn04 system. Syntheesis fo 6′-Methylene Derivatives of Neplanocin A as Potential Antiviral Nucleosides. New Neplanocin Analogues,” J. Org. Chem (1998), pp. 4489-4493, vol. 63.
Tominaga et al., “Studies on Positive Inotropic Agents.I. Synthesis of 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone and Related Compounds,” Chem. Pharm. Bull., (1984), pp. 2100-2110, vol. 32.
Tuner, “A General Approach to the Synthesis of 1,6-,1,7-, and 1,8-Naphthyridines,” J. Org. Chem., (1990), pp. 4744-4750, vol. 55.
Van Wijingaarden, “2-Phenylpyrroles as conformationally Restricted Benzamide Analogues. A New Class of Potential Antipsychotics. 2,” J. Med. Chem., (1988), pp. 1934-1940, vol. 31.
Wolfe et al., “Simple, Efficient Gatalyst System for the Palladium-Catalyzed Amination of Aryl Chlorides, Bromides, and Triflates,” J. Org. Chem., (2000), pp. 1158-1174, vol. 65.
Yoneda et al., “Facile Preparation of Aromatic Fluorides by Deaminative Fluorination of Aminoarenes Using Hydrogen Fluoride Combined with Bases,” Tetrahedron, (1996), pp. 23-36, vol. 52.
PCT International Search Report, PCT/IB2004/002665.
Nobuyuki, “Carbostyril Derivative and Therapeutic Agent for Schizophrenia Containing the Same Derivative”, Patent Abstracts of Japan, vol. 1996, No. 3, 1995 (JP 07 304741 abstract).
Nobuyuki, “Carbostyril Derivative”, Patent Abstracts of Japan, vol. 1996, No. 3, 1995 (JP 07 304740 abstract).
Shuji, “3,4-Dihydrocarbostyril Derivative”, Patent Abstracts of Japan, vol. 1996, No. 1, 1995 (JP 07 247271 abstract).
Nobuyuki, “Carbostyril Derivative and Therapeutic Agent for Schizophrenia Containing the Same Derivative”, Patent Abstracts of Japan, vol. 1995, No. 9, 1995 (JP 07 165720 abstract).
Nobuyuki, “Carbostyryl Derivative and Remedy for Schizophrenia Containing the Same”, Patent Abstracts of Japan, vol. 014, No. 466, 1990 (JP 02 191256 abstract).
Johnson Douglas S.
Repine Joseph Thomas
White Andrew David
Ashbrook Charles W.
Bernhardt Emily
Warner Lambert Company LLC
Zhang Austin W.
LandOfFree
[1,8]naphthyridin-2-ones and related compounds for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with [1,8]naphthyridin-2-ones and related compounds for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and [1,8]naphthyridin-2-ones and related compounds for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3779058